OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC.
A Study of Aripiprazole in Patients With Schizophrenia in General Psychiatric Practices
- Conditions
- First Posted Date
- 2006-02-16
- Last Posted Date
- 2013-11-08
- Target Recruit Count
- 400
- Registration Number
- NCT00292409
A Phase IV Study of the Safety and Efficacy of Aripiprazole in Combination With Lamotrigine in the Long-Term Maintenance Treatment of Patients With Bipolar I Disorder With A Recent Manic or Mixed Episode
- Conditions
- Interventions
- First Posted Date
- 2006-01-16
- Last Posted Date
- 2013-12-02
- Target Recruit Count
- 1169
- Registration Number
- NCT00277212
- Locations
- πΊπΈ
Sheppard Pratt Health System, Baltimore, Maryland, United States
πΊπΈNeuro Behavioral Clinical Research, Inc., Canton, Ohio, United States
πΊπΈBelmont Center For Comprehensive Treatment, Philadelphia, Pennsylvania, United States
A Study of Aripiprazole (Abilify) in Patients With Bipolar Mania
- Conditions
- Interventions
- First Posted Date
- 2005-12-05
- Last Posted Date
- 2023-04-18
- Target Recruit Count
- 1270
- Registration Number
- NCT00261443
- Locations
- πΊπΈ
Us Clinical Research Centers, Llc, Costa Mesa, California, United States
πΊπΈCns Research Institute, P.C., Clementon, New Jersey, United States
πΊπΈUniversity Of South Florida, Tampa, Florida, United States
Study of Aripiprazole in Patients With Bipolar I Disorder
- Conditions
- First Posted Date
- 2005-11-24
- Last Posted Date
- 2013-11-08
- Target Recruit Count
- 400
- Registration Number
- NCT00257972
- Locations
- π¬π§
Local Institution, Surbiton, Middlesex, United Kingdom
Aripiprazole for Schizophrenia Outpatients Completing BMS Clinical Trials
- First Posted Date
- 2005-10-17
- Last Posted Date
- 2014-12-19
- Target Recruit Count
- 119
- Registration Number
- NCT00239356
- Locations
- π¬π§
Local Institution, Antrim, United Kingdom
A Study of Aripiprazole in the Management of Patients With Schizophrenia in the General Psychiatric Practices
- Conditions
- First Posted Date
- 2005-10-13
- Last Posted Date
- 2013-11-08
- Target Recruit Count
- 1200
- Registration Number
- NCT00237939
- Locations
- πͺπΈ
Local Institution, Sevilla, Spain
Schizophrenia Trial of Aripiprazole
- Conditions
- Interventions
- First Posted Date
- 2005-10-13
- Last Posted Date
- 2013-11-08
- Target Recruit Count
- 700
- Registration Number
- NCT00237913
- Locations
- π¬π§
Local Institution, Birmingham, West Midlands, United Kingdom
A Switch Study of BMS-337039 in Schizophrenic Out-patients
- First Posted Date
- 2005-10-05
- Last Posted Date
- 2013-11-08
- Target Recruit Count
- 450
- Registration Number
- NCT00232687
- Locations
- π¬π§
Local Institution, Haywards Health, West Sussex, United Kingdom
"SALT-2 Trial" Study of Ascending Levels of Tolvaptan in Hyponatremia
- Conditions
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2012-05-03
- Target Recruit Count
- 243
- Registration Number
- NCT00201994
- Locations
- π©πͺ
Universitatskilinikum Carl, Gustav Carus, Dresden, Germany
Study of Rebamipide Eye Drops to Treat Dry Eye
- Conditions
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2006-11-02
- Target Recruit Count
- 740
- Registration Number
- NCT00201955
- Locations
- πΊπΈ
Vision Incorporated, Savannah, Georgia, United States
πΊπΈPhiladelphia Eye Associates, Philadelphia, Pennsylvania, United States
πΊπΈWestern Wake Eye Center, P.A., Cary, North Carolina, United States